Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
3051
DELISTED
Ansys
ANSS
| $4.27M | ﹤0.01% |
22,899
+5,593
| +32% | +$1M |
|
3052
PUT
Sysco
SYY
$39.7B
| $4.27M | ﹤0.01% |
58,300
+22,300
| +62% | +$1.61M |
|
|
CEO
3053
CALL
DELISTED
CNOOC Limited
CEO
| $4.27M | ﹤0.01% |
21,600
-2,900
| -12% | -$492K |
|
3054
Emcor
EME
$36.9B
| $4.26M | ﹤0.01% |
56,790
+40,506
| +249% | +$3.12M |
|
3055
PUT
Cencora
COR
$59.9B
| $4.26M | ﹤0.01% |
46,200
-25,000
| -35% | -$2.16M |
|
|
NVTA
3056
DELISTED
Invitae Corporation
NVTA
| $4.26M | ﹤0.01% |
254,716
-170,589
| -40% | -$1.94M |
|
3057
Avient
AVNT
$4.25B
| $4.26M | ﹤0.01% |
97,449
-24,543
| -20% | -$1.07M |
|
3058
CALL
Equity Residential
EQR
$24.7B
| $4.25M | ﹤0.01% |
64,200
+11,300
| +21% | +$748K |
|
|
ONC
3059
PUT
BeOne Medicines Ltd
ONC
$39.3B
| $4.25M | ﹤0.01% |
24,700
+2,600
| +12% | +$437K |
|
|
FNSR
3060
DELISTED
Finisar Corp
FNSR
| $4.25M | ﹤0.01% |
223,287
-35,408
| -14% | -$659K |
|
3061
Idexx Laboratories
IDXX
$43.4B
| $4.25M | ﹤0.01% |
17,027
-7,022
| -29% | -$1.7M |
|
3062
Apollo Global Management
APO
$83.1B
| $4.24M | ﹤0.01% |
122,656
+104,791
| +587% | +$3.65M |
|
3063
iShares ESG Optimized MSCI USA ETF
SUSA
$4.19B
| $4.23M | ﹤0.01% |
70,922
+25,646
| +57% | +$1.5M |
|
3064
PUT
Baxter International
BAX
$13.8B
| $4.23M | ﹤0.01% |
54,900
+900
| +2% | +$66.8K |
|
|
MDR
3065
CALL
DELISTED
McDermott International
MDR
| $4.22M | ﹤0.01% |
229,200
+184,100
| +408% | +$3.44M |
|
3066
AMERISAFE
AMSF
$513M
| $4.22M | ﹤0.01% |
68,127
+15,378
| +29% | +$959K |
|
3067
State Street SPDR S&P Metals & Mining ETF
XME
$4.53B
| $4.22M | ﹤0.01% |
123,554
-12,141
| -9% | -$424K |
|
3068
Rayonier Advanced Materials
RYAM
$570M
| $4.22M | ﹤0.01% |
228,873
-133,793
| -37% | -$2.63M |
|
|
NVO
3069
CALL
Novo Nordisk
NVO
$201B
| $4.21M | ﹤0.01% |
178,600
-35,000
| -16% | -$854K |
|
3070
Mattel
MAT
$4.29B
| $4.21M | ﹤0.01% |
+268,116
| New | +$4.29M |
|
3071
PUT
Zimmer Biomet
ZBH
$19.2B
| $4.21M | ﹤0.01% |
32,960
+15,244
| +86% | +$1.81M |
|
3072
Applied Optoelectronics
AAOI
$12.7B
| $4.2M | ﹤0.01% |
+170,403
| New | +$6.68M |
|
3073
Williams-Sonoma
WSM
$28.4B
| $4.2M | ﹤0.01% |
127,836
+6,654
| +5% | +$211K |
|
3074
PUT
MPLX
MPLX
$60.3B
| $4.2M | ﹤0.01% |
121,100
+73,100
| +152% | +$2.62M |
|
|
WES
3075
DELISTED
Western Gas Partners Lp
WES
| $4.2M | ﹤0.01% |
96,142
+23,107
| +32% | +$1.15M |
|
Similar funds
Citadel Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Citadel Advisors held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Citadel Advisors's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Citadel Advisors added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Citadel Advisors's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Citadel Advisors fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Citadel Advisors opened 1,427 new positions and closed 1,043 in Q3 2018.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.